Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 02.10.2024
grenke AG
grenke achieves strong new business in Q3 2024
Leasing new business rises year-on-year by 24.9% in the third quarter, reaching EUR 738.5 million (Q3 2023: EUR 591.1 million)
Contribution margin 2 (CM2) grows by 29.1% to EUR 125.8 million (Q3 2023: EUR 97.4 million)
CM2 margin increases to 17.0% (Q3 2023: 16.5%)
Baden-Baden, October 2, 2024: [ … ]
Tue, 01.10.2024
grenke AG
grenke successfully concludes share buyback program
A total of 4.98% of the outstanding capital repurchased (2,317,695 shares)
Baden-Baden, October 1, 2024: grenke AG, a global financing partner for small and medium-sized enterprises, has successfully concluded the share buyback program it launched in February 2024. In the past 33 weeks, the com [ … ]
Tue, 01.10.2024
Pentixapharm Holding AG
NOT FOR DISTRIBUTION OR ANNOUNCEMENT, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR ANNOUNCEMENT WOULD BE UNLAWFUL
Disclosure of Insider Information according to Article 17 of Regulation (EU) No. 596/2014
Pentixapharm Holding AG: Place [ … ]
Tue, 01.10.2024
HBM Healthcare Investments AG
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
30.9.2024
01.10.2024 / 17:47 CET/CEST
in CHF
Performance in %
30.09.2024
MTD
FYTD
CYTD
NAV
244.34
5.6
1.5
[ … ]
Tue, 01.10.2024
HBM Healthcare Investments AG
HBM Healthcare Investments achieved a positive performance in the first half of the 2024/2025 financial year. The net asset value per share (NAV) increased by 1.5 per cent to CHF 244.34. The share price rose by 1.7 per cent to CHF 189.40.
Based on the reported NAV, the company expects a half-year profit of around CHF 23 million (previous year: los [ … ]
Tue, 01.10.2024
R&S Group Holding AG
R&S Group Holding AG
/ Key word(s): Miscellaneous
R&S Group warrants converted by 79%
01.10.2024 / 17:45 CET/CEST
Press Release
R&S Group warrants converted by 79%
1 October 2024 – R&S Group Holding AG (SIX: RSGN) today provides an update on the conversion status of its redeemable warrants which are [ … ]
Tue, 01.10.2024
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
Data from the study with the lead ADC candidate, HDP-101, show elimination of tumor cells in one patient
Clinical data from IMS will be presented in R&D webinar on 15 October at 17:00 CEST / 1 [ … ]
Tue, 01.10.2024
SMT Scharf AG
SMT Scharf AG requests change of stock ticker symbol
Hamm, October 01, 2024 – SMT Scharf AG (WKN: A3DRAE; ISIN: DE000A3DRAE2), a leading global provider of customised transport solutions and logistics systems for the underground mining industry, announces that it has requested today to change the stock ticker symbol. It is anticipated that, with e [ … ]
Tue, 01.10.2024
Samara Asset Group p.l.c.
Public Disclosure under MAR Article 17
Samara Asset Group p.l.c. contemplates to issue a EUR 30 million bond
Sliema/Malta, 1 October 2024 –The Board of Directors of Samara Asset Group p.l.c. (ISIN: MT0001770107; Ticker: SRAG:GR) (“Company”) contemplates to issue a secured bond in the total amount of up to EUR 30 million. The Company intends to [ … ]
Tue, 01.10.2024
Formycon AG
Company Name:
Formycon AG
ISIN:
DE000A1EWVY8
Reason for the research:
FYB202 approval in EU and US
Recommendation:
Buy
from:
01.10.2024
Target price:
€82
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Simon Scholes
First Berlin Equity Research has published a research update on Formycon AG (ISIN: DE000 [ … ]